DIARRHOEA is the #10 most commonly reported adverse reaction for INSULIN GLARGINE, manufactured by sanofi-aventis U.S. LLC. There are 6,900 FDA adverse event reports linking INSULIN GLARGINE to DIARRHOEA. This represents approximately 1.7% of all 399,332 adverse event reports for this drug.
Patients taking INSULIN GLARGINE who experience diarrhoea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
Reporting Frequency
DIARRHOEA6,900 of 399,332 reports
DIARRHOEA is a less commonly reported adverse event for INSULIN GLARGINE, but still significant enough to appear in the safety profile.
Other Side Effects of INSULIN GLARGINE
In addition to diarrhoea, the following adverse reactions have been reported for INSULIN GLARGINE:
DIARRHOEA has been reported as an adverse event in 6,900 FDA reports for INSULIN GLARGINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
How common is DIARRHOEA with INSULIN GLARGINE?
DIARRHOEA accounts for approximately 1.7% of all adverse event reports for INSULIN GLARGINE, making it a notable side effect.
What should I do if I experience DIARRHOEA while taking INSULIN GLARGINE?
If you experience diarrhoea while taking INSULIN GLARGINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.